Yun-Fei Zhu

Yun-Fei (Frank) Zhu (Vice President, Chemistry) is a Founder of Crinetics Pharmaceuticals. He received his Ph.D. in Organic Chemistry from Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences in China, and pursued his postdoctoral studies in the laboratory of Professor Murray Goodman in Department of Chemistry, University of California, San Diego. He joined Neurocrine Biosciences in 1997 where he led chemistry efforts on discovery of nonpeptide GnRH antagonists. He was most recently a Director of Chemistry in the Endocrinology and Metabolism group. His research has involved discovery of small molecule inhibitors of several neuropeptide receptors including CRFR2, MCH receptor, and GnRH-R for the treatment of a range of endocrine diseases.

Yun-Fei Zhu is the Co-Founder & Vice President, Chemistry at Crinetics Pharmaceuticals, based in United States, North America. With a background in Biotechnology, Yun-Fei Zhu has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.